Hepatic arterial embolization procedures in neuroendocrine tumors with carcinoid heart disease: a retrospective single-center study on safety and feasibility
Endocrine-Related Cancer · 01.07.2026 · 33 (7)
DOI: 10.1530/erc-26-0128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine-Related Cancer, online erschienen am 11.07.2026. Verfasst von Théodore Vuong und 14 weiteren Autor:innen. Beteiligte Einrichtung: Département d'Anesthésie Chirurgie et Interventionnel (DACI), Service d'Imagerie Thérapeutique, Gustave Roussy , Villejuif, France. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hepatic arterial embolization reduces liver tumor burden and hormonal secretion in neuroendocrine tumors, but its safety in patients with carcinoid heart disease is underexplored, and current guidelines suggest managing the cardiac disease first. We assessed the safety and efficacy of hepatic arterial embolization in patients with neuroendocrine tumors and concomitant carcinoid heart disease in a single-center retrospective study including patients with liver metastases and carcinoid heart disease confirmed on expert transthoracic echocardiography between 2001 and 2025. The primary endpoint was procedural safety; secondary endpoints were symptom control, biochemical response, and overall survival. Twenty-seven patients (median age: 58.6 years) underwent 69 embolization procedures using bland, conventional, and drug-eluting bead techniques. Severe carcinoid heart disease was present in 52% of patients, and right-sided valvular disease was found in 96%, with tricuspid regurgitation predominating. No procedure-related or cardiovascular death occurred. Two cardiac complications (7%) arose, both in patients with severe pre-existing valvular disease, together with four extra-cardiac complications. Carcinoid syndrome symptoms and urinary 5-hydroxyindoleacetic acid levels decreased significantly after treatment, whereas cardiac symptoms remained stable. The median overall survival was 6.25 years, with a 5-year survival of 60%. Hepatic arterial embolization appears feasible with an acceptable safety profile in patients with neuroendocrine tumors and concomitant carcinoid heart disease when performed in expert centers with multidisciplinary management and may contribute to carcinoid syndrome control. Prospective multicenter studies are warranted to confirm these findings and define the optimal sequencing of hepatic arterial embolization and cardiac valve surgery. Key findings
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Département d'Anesthésie Chirurgie et Interventionnel (DACI), Service d'Imagerie Thérapeutique, Gustave Roussy , Villejuif, France.
- Faculté de Médecine, Université Paris-Saclay , Le Kremlin-Bicêtre, France.
- Département de Médecine Oncologique, Gustave Roussy , Villejuif, France.
- Institut d'Oncologie Thoracique, Hôpital Marie Lannelongue , Le Plessis-Robinson, France.
- Département d'Anesthésie Chirurgie et Interventionnel (DACI), Service de Chirurgie Digestive, Gustave Roussy , Villejuif, France.
- Service de Cardiologie, Hôpital Pitié-Salpêtrière , Paris, France.
ORCID-Profile: Théodore Vuong, Julien Hadoux
Zitieren
APA
Vuong, T., Tselikas, L., Hadoux, J., Smaali, S., Faron, M., De Baère, T., Lamartina, L., Moog, S., Fernandez De Sevilla, E., Beunon, P., Ederhy, S., Menu, Y., Deschamps, F., Baudin, É., & Bonnet, B. (2026). Hepatic arterial embolization procedures in neuroendocrine tumors with carcinoid heart disease: a retrospective single-center study on safety and feasibility. Endocrine-Related Cancer, 33(7). https://doi.org/10.1530/erc-26-0128
Vancouver
Vuong T, Tselikas L, Hadoux J, Smaali S, Faron M, De Baère T, et al. Hepatic arterial embolization procedures in neuroendocrine tumors with carcinoid heart disease: a retrospective single-center study on safety and feasibility. Endocrine-Related Cancer. 2026;33(7). doi:10.1530/erc-26-0128
BibTeX
@article{Vuong2026,
author = {Vuong, Théodore and Tselikas, Lambros and Hadoux, Julien and Smaali, Sondés and Faron, Matthieu and De Baère, Thierry and Lamartina, Livia and Moog, Sophie and Fernandez De Sevilla, Elena and Beunon, Paul and Ederhy, Stéphane and Menu, Yves and Deschamps, Frédéric and Baudin, Éric and Bonnet, Baptiste},
title = {Hepatic arterial embolization procedures in neuroendocrine tumors with carcinoid heart disease: a retrospective single-center study on safety and feasibility},
journal = {Endocrine-Related Cancer},
year = {2026},
volume = {33},
number = {7},
doi = {10.1530/erc-26-0128}
}
EUVIMED